These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20812851)

  • 21. Gamma interferon production in response to Mycobacterium bovis BCG and Mycobacterium tuberculosis antigens in infants born to human immunodeficiency virus-infected mothers.
    Van Rie A; Madhi SA; Heera JR; Meddows-Taylor S; Wendelboe AM; Anthony F; Violari A; Tiemessen CT
    Clin Vaccine Immunol; 2006 Feb; 13(2):246-52. PubMed ID: 16467333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inactivated
    Kuczkowska K; Copland A; Øverland L; Mathiesen G; Tran AC; Paul MJ; Eijsink VGH; Reljic R
    Front Immunol; 2019; 10():1588. PubMed ID: 31354727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of host responses to Mycobacterium tuberculosis antigens in a multi-site study of subjects with different TB and HIV infection states in sub-Saharan Africa.
    Sutherland JS; Lalor MK; Black GF; Ambrose LR; Loxton AG; Chegou NN; Kassa D; Mihret A; Howe R; Mayanja-Kizza H; Gomez MP; Donkor S; Franken K; Hanekom W; Klein MR; Parida SK; Boom WH; Thiel BA; Crampin AC; Ota M; Walzl G; Ottenhoff TH; Dockrell HM; Kaufmann SH;
    PLoS One; 2013; 8(9):e74080. PubMed ID: 24040170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disseminated tuberculosis in human immunodeficiency virus infection: ineffective immunity, polyclonal disease and high mortality.
    von Reyn CF; Kimambo S; Mtei L; Arbeit RD; Maro I; Bakari M; Matee M; Lahey T; Adams LV; Black W; Mackenzie T; Lyimo J; Tvaroha S; Waddell R; Kreiswirth B; Horsburgh CR; Pallangyo K
    Int J Tuberc Lung Dis; 2011 Aug; 15(8):1087-92. PubMed ID: 21740673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-lived immune response to early secretory antigenic target 6 in individuals who had recovered from tuberculosis.
    Wu-Hsieh BA; Chen CK; Chang JH; Lai SY; Wu CH; Cheng WC; Andersen P; Doherty TM
    Clin Infect Dis; 2001 Oct; 33(8):1336-40. PubMed ID: 11565073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ESAT-6 Targeting to DEC205+ Antigen Presenting Cells Induces Specific-T Cell Responses against ESAT-6 and Reduces Pulmonary Infection with Virulent Mycobacterium tuberculosis.
    Silva-Sánchez A; Meza-Pérez S; Flores-Langarica A; Donis-Maturano L; Estrada-García I; Calderón-Amador J; Hernández-Pando R; Idoyaga J; Steinman RM; Flores-Romo L
    PLoS One; 2015; 10(4):e0124828. PubMed ID: 25915045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of polyfunctional Mycobacterium tuberculosis-specific T cells and association with viral load in HIV-1-infected persons.
    Day CL; Mkhwanazi N; Reddy S; Mncube Z; van der Stok M; Klenerman P; Walker BD
    J Infect Dis; 2008 Apr; 197(7):990-9. PubMed ID: 18419535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IFN-γ response on T-cell based assays in HIV-infected patients for detection of tuberculosis infection.
    Latorre I; Martínez-Lacasa X; Font R; Lacoma A; Puig J; Tural C; Lite J; Prat C; Cuchi E; Ausina V; Domínguez J
    BMC Infect Dis; 2010 Dec; 10():348. PubMed ID: 21143955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans.
    Rangaka MX; Diwakar L; Seldon R; van Cutsem G; Meintjes GA; Morroni C; Mouton P; Shey MS; Maartens G; Wilkinson KA; Wilkinson RJ
    Clin Infect Dis; 2007 Jun; 44(12):1639-46. PubMed ID: 17516410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrent tuberculosis risk among HIV-infected adults in Tanzania with prior active tuberculosis.
    Lahey T; Mackenzie T; Arbeit RD; Bakari M; Mtei L; Matee M; Maro I; Horsburgh CR; Pallangyo K; von Reyn CF
    Clin Infect Dis; 2013 Jan; 56(1):151-8. PubMed ID: 22972862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice.
    Kim A; Hur YG; Gu S; Cho SN
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of Mycobacterium tuberculosis early secretory antigenic target-6 protein and its application in detection of Mycobacterium tuberculosis antigen-specific interferon-gamma response].
    Zhang J; Liu WL; Zhou BP; Zhang MX; Yang QT; Zhu XY; Lu J; Deng QY; Chen XC
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Jan; 32(1):55-9. PubMed ID: 19484964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The immune response to Mycobacterium tuberculosis in HIV-infected and uninfected adults in Uganda: application of a whole blood cytokine assay in an epidemiological study.
    Elliott AM; Hurst TJ; Balyeku MN; Quigley MA; Kaleebu P; French N; Biryahwaho B; Whitworth JA; Dockrell HM; Hayes RJ
    Int J Tuberc Lung Dis; 1999 Mar; 3(3):239-47. PubMed ID: 10094326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-gamma production by mononuclear cells in Bacille Calmette-Guérin-revaccinated healthy volunteers predicted long-term antimycobacterial responses in a randomized controlled trial.
    Oliveira ES; Marinho JM; Barbosa T;
    Vaccine; 2013 Aug; 31(37):3778-82. PubMed ID: 23684832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human immunodeficiency virus (HIV) infection during pregnancy induces CD4 T-cell differentiation and modulates responses to Bacille Calmette-Guérin (BCG) vaccine in HIV-uninfected infants.
    Miles DJ; Gadama L; Gumbi A; Nyalo F; Makanani B; Heyderman RS
    Immunology; 2010 Mar; 129(3):446-54. PubMed ID: 20002789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901.
    von Reyn CF; Lahey T; Arbeit RD; Landry B; Kailani L; Adams LV; Haynes BC; Mackenzie T; Wieland-Alter W; Connor RI; Tvaroha S; Hokey DA; Ginsberg AM; Waddell R
    PLoS One; 2017; 12(5):e0175215. PubMed ID: 28498853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ESAT-6-dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo.
    Kupz A; Zedler U; Stäber M; Perdomo C; Dorhoi A; Brosch R; Kaufmann SH
    J Clin Invest; 2016 Jun; 126(6):2109-22. PubMed ID: 27111234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of protective efficacy conferred by a recombinant Mycobacterium bovis BCG expressing a fusion protein of Ag85A-ESAT-6.
    Deng YH; He HY; Zhang BS
    J Microbiol Immunol Infect; 2014 Feb; 47(1):48-56. PubMed ID: 23357605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
    Li W; Li M; Deng G; Zhao L; Liu X; Wang Y
    Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.